The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 25 2025 for Ravi Agrawal trustee Ravi Agrawal Trust
26-Sep-2025
Download PDF
Ajanta Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 25 2025 for Ravi Agrawal trustee Ravi Agrawal Trust